CATHEDRAL MEDICAL CENTRE — All Prescriptions & Medications
Practice Code: Y00185 | ELY, CB6 1DN
Over the last 12 months, CATHEDRAL MEDICAL CENTRE prescribed 221,489 items across 598 different medications at a total cost of £1,767,962 to the NHS. Below is the complete list of all medications prescribed, sorted by volume.
| Medication | Items (12m) ↑ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Zinc oxide | 10 | 212 | £27 | -51.7% ▼ |
| Hydralazine hydrochloride | 10 | 2,520 | £129 | -76.3% ▼ |
| Clonidine hydrochloride | 10 | 644 | £50 | -45.3% ▼ |
| Aclidinium bromide | 10 | 10 | £309 | -62.3% ▼ |
| Fluticasone furoate/vilanterol | 10 | 10 | £259 | -93.5% ▼ |
| Valproic acid | 10 | 840 | £303 | -88.5% ▼ |
| Clindamycin phosphate | 10 | 400 | £103 | +139.7% ▲ |
| Ulipristal acetate (Emergency Contraceptive) | 10 | 10 | £134 | +131.5% ▲ |
| Calcitriol | 10 | 280 | £49 | -35.9% ▼ |
| RtS 1.4 - 2 kcal/g dessert style (milk based) (0913011) | 10 | 26.5K | £333 | -73.8% ▼ |
| Powder amino acid formula (0913107) | 10 | 24.4K | £1.6K | -69.7% ▼ |
| Cocois | 10 | 520 | £103 | -27.2% ▼ |
| Amorolfine hydrochloride | 10 | 50 | £60 | -56.7% ▼ |
| Other individually formulated bought in preparations | 10 | 1,068 | £135 | -69.4% ▼ |
| 10 | 500 | £140 | -26.8% ▼ | |
| 10 | 340 | £72 | +117.2% ▲ | |
| 10 | 32 | £832 | +9.8% ▲ | |
| 10 | 22 | £545 | +120.7% ▲ | |
| 10 | 100 | £68 | -76.8% ▼ | |
| 10 | 50 | £139 | +6.9% ▲ | |
| 10 | 110 | £304 | -79.1% ▼ | |
| 10 | 400 | £216 | -27.8% ▼ | |
| 10 | 400 | £1.3K | -12.2% ▼ | |
| Methyldopa | 11 | 990 | £217 | -35.4% ▼ |
| Moxonidine | 11 | 616 | £73 | -80.2% ▼ |
| Oxytetracycline | 11 | 896 | £383 | -57.4% ▼ |
| Denosumab | 11 | 11 | £1.9K | -59.6% ▼ |
| Norethisterone | 11 | 1,722 | £41 | -21.3% ▼ |
| Mercaptopurine | 11 | 462 | £219 | -29.0% ▼ |
| Other phosphate supplement preparations | 11 | 420 | £81 | +80.3% ▲ |
| Sevelamer | 11 | 2,628 | £432 | -49.8% ▼ |
| Tablets/capsules micronutrient supplement (0913282) | 11 | 660 | £464 | +5.0% ▲ |
| Ciprofloxacin | 11 | 180 | £69 | +19.3% ▲ |
| 11 | 110 | £14 | +96.5% ▲ | |
| 11 | 1,320 | £2.3K | -48.0% ▼ | |
| 11 | 480 | £340 | -66.7% ▼ | |
| 11 | 780 | £110 | -16.6% ▼ | |
| 11 | 510 | £1.2K | -46.3% ▼ | |
| Amisulpride | 12 | 336 | £120 | -82.9% ▼ |
| Modafinil | 12 | 2,016 | £138 | -42.4% ▼ |
| Ondansetron hydrochloride | 12 | 278 | £110 | -75.3% ▼ |
| Nefopam hydrochloride | 12 | 1,168 | £51 | -89.4% ▼ |
| Dapsone | 12 | 336 | £80 | +16.1% ▲ |
| Ofloxacin | 12 | 340 | £415 | +46.0% ▲ |
| Itraconazole | 12 | 198 | £92 | -10.6% ▼ |
| Valaciclovir | 12 | 300 | £369 | -14.6% ▼ |
| Canagliflozin | 12 | 315 | £392 | -91.6% ▼ |
| Ins degludec/liraglutide | 12 | 72 | £2.3K | -25.4% ▼ |
| Oestrogens conjugated | 12 | 1,428 | £499 | -41.2% ▼ |
| Vardenafil | 12 | 48 | £86 | -14.1% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.